Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone pulse therapy in children with refractory epilepsy
IRCT20240615062138N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methylprednisolone in epilepsy, sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2023; status: completed.
02
Drugs
methylprednisolone
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20240615062138N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240615062138N1.